HUBUNGAN HIPERTENSI DENGAN TINGKAT MORTALITAS PASIEN COVID-19 DI RSUD DR. SLAMET GARUTTAHUN 2020-2021
DOI:
https://doi.org/10.31004/jkt.v4i3.17078Keywords:
covid-19, hipertensi, mortalitasAbstract
COVID-19 menginfeksi orang-orang dari semua kelompok umur, namun individu yang memiliki usia 60 tahun ke atas, bersama penyakit bawaan layaknya diabetes, penyakit paru obstruktif kronik, hipertensi, dan penyakit jantung, memiliki risiko lebih tinggi terkena infeksi. Risiko kematian pasien covid-19 diketahui juga meningkat pada individu yang memiliki penyakit penyerta. Penyakit penyerta pada pasien COVID-19 dinilai memiliki output yang lebih buruk dan dapat berujung pada kematian. Penyakit penyerta yang paling banyak di jumpai pada pasien COVID-19 di Indonesia ialah hipertensi. Penelitian ini bertujuan untuk mengetahui hubungan antara hipertensi dengan tingkat mortalitas pada pasien COVID-19. Penelitian ini merupakan penelitian analitik dengan pendekatan cross-sectional yang dilakukan di RSUD dr. Slamet Garut. Populasi dan sampel dalam penelitian ini adalah seluruh pasien yang terdiagnosis COVID-19 pada periode 2020-2021 dan memiliki penyakit penyerta hipertensi. Penelitian ini dilakukan dari tanggal 2 hingga 28 Februari 2023. Teknik pengambilan sampel adalah purposive sampling yaitu sebanyak 117 orang. Alat pengumpulan data menggunakan data sekunder yaitu rekam medis pasien yang terkonfirmasi COVID-19 dengan hipertensi dan dirawat di RSUD dr.Slamet Garut Tahun 2020-2021. Penelitian menggunakan metode purposive sampling dengan kriteria inklusi dan eksklusi. Analisis data dengan Uji Chi-Square yang dilakukan menggunakan software SPSS 25. Tidak terdapat hubungan antara hipertensi dan mortalitas pasien COVID-19 (p=0,0870). Tidak terdapat hubungan yang signifikan antara hipertensi dan mortalitas pasien COVID-19.References
Azhar, Z., Widyastuti, C. T., Rajin, M., Fatmawati, D. A., Mawarti, H., Info, A., & Disease, C. (2021). Relationship Of Comorbid Disease To Mortality Events In Covid-19 Patients. 1(2), 135–142.
Choirunnisa, & Helda. (2021). Hubungan Hipertensi dengan Mortalitas Pasien Covid-19 di Tangerang Selatan. Jurnal Epidemiologi Kesehatan Indonesia, 5(2). https://doi.org/10.7454/epidkes.v5i2.5265
Clark, C. E., Martin, U., & J, sinead T. (2021). COVID-19 and hypertension?: risks and management . A scienti fi c statement on behalf of the British and Irish Hypertension Society. Journal of Human Hypertension, 35, 304–307. https://doi.org/10.1038/s41371-020-00451-x
Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., & Junaid, K. (2020). COVID-19 and comorbidities: Deleterious impact on infected patients. Journal of Infection and Public Health, 13(January), 1833–1839.
Gagat, A. (2020). Mengulik Usia Pasien Positif Covid-19 di Jakarta. Dinas Kesehatan DKI Jakarta. https://corona.jakarta.go.id/id/artikel/mengulik-usia-pasien-positif-covid-19-di-jakartaDi
Gallo, G., Calvez, V., & Savoia, C. (2022). Hypertension and COVID ? 19?: Current Evidence and Perspectives. High Blood Pressure & Cardiovascular Prevention, 29(2), 115–123. https://doi.org/10.1007/s40292-022-00506-9
Grippo, F., Navarra, S., Orsi, C., Manno, V., Grande, E., Crialesi, R., Frova, L., Marchetti, S., Pappagallo, M., Simeoni, S., Di Pasquale, L., Carinci, A., Donfrancesco, C., Lo Noce, C., Palmieri, L., Onder, G., & Minelli, G. (2020). The role of COVID-19 in the death of sars-COV-2–positive patients: A study based on death certificates. Journal of Clinical Medicine, 9(11), 1–13. https://doi.org/10.3390/jcm9113459
Gugus Tugas Percepatan Penanganan Covid 19 Garut. (2021). RSUD dr. SLAMET GARUT. HANAPI. https://www.garutkab.go.id/skpd_news/rsud-dr-slamet-dan-3-rs-lain-jadi-rumah-sakit-rujukan-covid-19-di-kabupaten-garut
Imam, Z., Odish, F., Gill, I., O’Connor, D., Armstrong, J., Vanood, A., Ibironke, O., Hanna, A., Ranski, A., & Halalau, A. (2020). Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. Journal of Internal Medicine, 288(4), 469–476. https://doi.org/10.1111/joim.13119
Indonesian Society of Hypertension. (2021). Konsensus Penatalaksanaan Hipertensi 2021?: Update Konsensus PERHI 2019. In Perhimpunan Dokter Hipertensi Indonesia (pp. 1–66).
Jaya, I. (2021). Penguatan Sistem Kesehatan dalam Pengendalian COVID-19. Direktorat Jendral Pencegahan Penyakit. http://p2p.kemkes.go.id/penguatan-sistem-kesehatan-dalam-pengendalian-covid-19/
Karyono, D. R., & Wicaksana, A. L. (2020). Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. Journal of Community Empowerment for Health, 3(2), 77. https://doi.org/10.22146/jcoemph.57325
Kemenkes. (2020). Pasien Covid Yang Meninggal Memiliki Hipertensi. Kementrian Kesehatan RI. https://www.kemkes.go.id/article/print/20101400002/13-2-persen-pasien-covid-19-yang-meninggal-memiliki-penyakit-hipertensi.html
Kemenkes RI. (2019). Hipertensi Si Pembunuh Senyap. In Kementrian Kesehatan RI (pp. 1–5). https://pusdatin.kemkes.go.id/resources/download/pusdatin/infodatin/infodatin-hipertensi-si-pembunuh-senyap.pdf
Kemenkes RI. (2022). Menteri Kesehatan Tetapkan 132 Rumah Sakit Rujukan COVID-19. Infeksi Emerging. https://infeksiemerging.kemkes.go.id/info-corona-virus/menteri-kesehatan-tetapkan-132-rumah-sakit-rujukan-covid-19
Kementerian Kesehatan RI. (2018). Laporan Provinsi Jawa Barat, Riskesdas 2018. In Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan 2019.
kementrian kesehatan indonesia. (2020). Keputusan Menteri Kesehatan Repubik Indonesia Nomor HK.01.07/MENKES/169/2020 Tentang Penetapan Rumah Sakit Rujukan Penanggulangan Penyakit Infeksi Emerging Tertentu. 1–9. https://doi.org/10.1016/j.tmaid.2020.101607%0Ahttps://doi.org/10.1016/j.ijsu.2020.02.034%0Ahttps://onlinelibrary.wiley.com/doi/abs/10.1111/cjag.12228%0Ahttps://doi.org/10.1016/j.ssci.2020.104773%0Ahttps://doi.org/10.1016/j.jinf.2020.04.011%0Ahttps://doi.o
Keputusan Menteri Kesehatan Republik Indonesia. (2020). Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MenKes/413/2020 Tentang Pedoman Pencegahan dan Pengendalian Corona Virus Disease 2019 (Covid-19) (p. 207).
PAHO. (2020). No Title. PAHO. https://iris.paho.org/handle/10665.2/54401
Parveen, R., Sehar, N., Bajpai, R., & Bharal, N. (2020). Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis. Diabetes Research and Clinical Practice.
Pemerintah Jawa Barat. (2022). PIKOBAR. PIKOBAR. https://pikobar.jabarprov.go.id/distribution-case
Riset Kesehatan Dasar. (2018). Laporan Nasional RKD 2018. In Badan Penelitian dan Pengembangan Kesehatan 2019 (pp. 221–222). http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf
Rodilla, E., López-carmona, M. D., Cortes, X., Cobos-palacios, L., Canales, S., Sáez, M. C., Escudero, S. C., Rubio-rivas, M., Manglano, J. D., Castro, S. J. F., Piqueras, N. V., Sanchis, E. M., Maria, P., Fontan, P., Oskar, J., Gamboa, M., García, A. G., Romero, V. M., Chamorro, L. T., … Network, S.-. (2021). Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain. March, 856–867. https://doi.org/10.1161/HYPERTENSIONAHA.120.16563
Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, January, 5411–5413. https://doi.org/10.1109/BigData.2018.8622377
Sun, Y., Guan, X., Jia, L., Xing, N., Cheng, L., Liu, B., Zhang, S., & He, K. (2021). Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital. Journal of Clinical Hypertension, 23(2), 218–231. https://doi.org/10.1111/jch.14146
WHO. (2020). PHEIC COVID-19. WHO. https://www.who.int/publications/m/item/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum
WHO. (2021). COVID WHO. WHO. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19
Yang, J., Zheng, Y., Gou, X., Pu, K., & Chen, Z. (2020). Prevalence of Comorbidities and Its Effects in Patients infected with SARS-CoV-2: A Systematic Review and Meta-Analysis. International Journal of Infectious Diseases, 94(March), 91–95. https://doi.org/10.1016/j.arteri.2020.10.001
Zhou, F., Yu, T., & Du, R. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 395.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Alma Lucyati, Abiyyu Sulthan Pratama, Sophan Yahya Warnasouda, Lenny Oktorina, Steffi Rifasa
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
